Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models - Test2 - elhamkhani - TriplyDB

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

http://www.wikidata.org/entity/Q24796232

about

The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention Heterogeneity of mammary lesions represent molecular differences Phase I/Ib study of olaparib and carboplatin in women with triple negative breast cancer.Genetically engineered ERα-positive breast cancer mouse models.Activation of Akt1 accelerates carcinogen-induced tumorigenesis in mammary gland of virgin and post-lactating transgenic mice Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA.Breast Tissue Metabolism by Magnetic Resonance Spectroscopy.The cytoplasmic domain of MUC1 induces hyperplasia in the mammary gland and correlates with nuclear accumulation of β-catenin.SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma.Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome Therapeutic effects of lentivirus-mediated shRNA targeting of cyclin D1 in human gastric cancer.PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus Mouse models of estrogen receptor-positive breast cancer Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence.Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component.Role of cyclin D1 in breast carcinoma Differential Expression of Key Signaling Proteins in MCF10 Cell Lines, a Human Breast Cancer Progression Model Transcription factor IID recruitment and Sp1 activation. Dual function of TAF1 in cyclin D1 transcription.Development of an eight gene expression profile implicating human breast tumours of all grade.CDK4/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment Failure.Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth.Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.Ethanolic Neem (Azadirachta indica) Leaf Extract Prevents Growth of MCF-7 and HeLa Cells and Potentiates the Therapeutic Index of Cisplatin.Development of cell-cycle inhibitors for cancer therapy.Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis.Nonmonotonic Pathway Gene Expression Analysis Reveals Oncogenic Role of p27/Kip1 at Intermediate Dose.The role of CCND1 alterations during the progression of cutaneous malignant melanoma.Downregulation and antiproliferative role of FHL3 in breast cancer.Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.Bioinformatics Prediction and In Vitro Analysis Revealed That miR-17 Targets Cyclin D1 mRNA in Triple Negative Breast Cancer Cells.Cell Cycle Regulation in Treatment of Breast Cancer.Evaluation of the Role Played by Cyclin D1 as a Diagnostic and Prognostic Marker in the Progression of Oral Carcinogenesis

P2860

Q21245733-2092B909-F9AE-455F-B96A-CAE734DE15E3 Q33265521-BCF5B135-618A-4792-81C5-47DF33EDBFE1 Q33440778-C75C8480-86DB-45B5-81C6-352E89525F7E Q33578641-EEFE3536-94EF-4777-99E0-7404FB20F45D Q33612060-5FD6168E-0054-4A58-977E-0B738B5050B8 Q33714951-92BD54FB-DA2D-48E9-A849-293001A486FA Q33844954-2EA96190-826B-4989-A5E9-1B7E06A28043 Q33886076-285000D7-1B30-4305-839A-A693489DB928 Q34452617-5A15DEA3-994B-477D-A7D5-A23546C58A84 Q34517533-14816080-F98A-49C9-A8BA-96CF9F083BC7 Q34530428-53FC9DD8-8BAA-49E2-B4BD-5A5612A2586A Q35117351-A1A1788B-42D3-47EB-8CC6-65000EEBE57F Q35128090-E44B6ECD-6573-42CA-981D-C0BAFFA036D1 Q35685892-DD14C95C-2C91-488B-AFA2-A8D5C8ACF75A Q36238230-515D9A52-870F-4074-A77C-1548A39A7DEE Q36671557-320587B6-3D29-4D32-B5FB-208DF8BA8D9B Q36944192-143E5C7D-FFA7-41CD-985E-87E96570398A Q37536936-F11EC65B-7279-497F-9F52-36B1AF31D689 Q37591395-0A66AA96-60E9-45D5-8DB7-8325E8584C9A Q38357984-4E692059-D36A-4DBD-B191-ED0F7E2C32E1 Q38409249-2B1DA662-A209-4EB2-832F-4A0393A67587 Q39289608-BE2066E9-7A40-4377-9E2D-186D7783A076 Q39784275-E27112B3-801A-4FC5-95CA-9443248171C3 Q40486142-E76F6F7B-CAD2-4FF9-8E8F-37B346A8FF67 Q41966079-85D11A62-B862-4C03-9C07-8E0AA041BC01 Q43145495-50CEA816-4CBB-421E-8694-23EBBBCE616C Q44221016-BFA57C27-BBFF-45FA-A7D2-4C307232121A Q44396851-096ECB54-474D-49CF-896D-379A17A8B7E3 Q44763194-BCF39B9F-E8D5-447E-98C7-89DB4DB9D727 Q45877400-936B980B-A376-4B43-A727-6F03D22D44D5 Q47132908-C7150687-897F-423E-8FA5-66EFDC4D329E Q47399931-042ED9B9-C6F3-4FFD-BE4C-92A588C9EB16 Q47904838-EAEFA015-C962-40F9-A995-1C1BC35E55CC Q49544319-CC48F30F-DC67-4BF7-886E-703B71530928 Q56516873-22D6D422-76A8-47CF-B7E6-CB57D8B8393A

P2860

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

http://www.wikidata.org/entity/Q24796232

description

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

@ast

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

@en

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

@nl

type

label

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

@ast

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

@en

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

@nl

prefLabel

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

@ast

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

@en

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

@nl

P1433

Q24796232-70B61901-F340-4E2F-8FDF-9240696EFB3F

P1476

Q24796232-1D7D4A0F-EC34-4CD4-8CB9-76B7718FD197

P2093

Q24796232-0BB70BA3-7997-4DD0-9376-C7ED7C7B16BF

Q24796232-21FA6C1D-B750-41F1-BC68-92345F5499EF

P2860

Q24796232-06F80969-4538-4A91-8008-5EC1AA104A54

Q24796232-0EA0271D-7703-4EBA-86D1-3E1F30108604

Q24796232-12080F09-112F-4AAF-9AF4-A0D1657001FA

Q24796232-2CC66D09-6B0B-4B40-BDE3-58D6979327D8

Q24796232-3611AB1D-9DE5-4AB9-9AC6-DC163F0B2425

Q24796232-5C8312BC-79B6-4DE6-A6F1-7CFF86798E53

Q24796232-5E81A697-C9FF-49AE-8B83-721937468F54

Q24796232-711CEBDA-D6F6-4FA3-A9C8-4AE4A607A1ED

Q24796232-79EA66AA-0EC1-407C-B8E7-55CC330CCC6C

Q24796232-9B242511-4DE9-4B2D-9DBB-526AE8FA1C08

P2888

Q24796232-E9F46E20-A11A-419A-91C9-71EA7312C466

P304

Q24796232-88B271AB-AE71-40C0-8A5B-CF1995CD7EC5

P31

Q24796232-89FE457D-4AC8-45B5-8C38-ADAE31B4AD6C

Q24796232-D3AA810A-BC1E-43B3-9EE9-6CD328F53295

P356

Q24796232-009CDC9B-1D24-4D74-B280-B28E683FB2E1

P407

Q24796232-30C52AF1-068A-47F9-B0E4-D3D4279F713B

P433

Q24796232-6B7D4F02-0CFD-4BA8-9C29-DDAA18948F70

P478

Q24796232-7390FB48-2F74-4DED-8BCE-AC16722A4D3D

P577

Q24796232-43183955-3215-44F1-916B-8BE5B3F277D9

Q24796232-B60ED2B7-4501-4611-8882-99B8E887B281

P5875

Q24796232-07D08592-9149-4CE9-879C-68BBE9CF624A

P6179

Q24796232-B0F71E9D-8052-4E18-A9C1-BCC1D82533E0

P698

Q24796232-440830E8-95D1-46F0-9280-4712635EF7AE

P921

Q24796232-298B195F-D523-4E62-94C7-41589E877372

Q24796232-4DB73C25-A167-4C19-9EFF-1A79DB64C94E

Q24796232-50C05833-FA29-4B73-9163-10628A7A9630

Q24796232-BA4B5A8A-385B-48E8-9CC9-8BF0BE22F286

Q24796232-BA93C0D7-25F5-4A9C-BF69-711D3FF2F9E9

Q24796232-E41851EB-BB4F-4F4D-A982-6A090F5E6F25

Q24796232-EBE21B80-7127-4DAE-9A19-C24DC10E9564

P932

Q24796232-96C9DAC0-B8D2-4362-96D0-1CE293EDB570

P356

P1433

Breast Cancer Research

P1476

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models

@en

P2093

Elizabeth A Musgrove

http://www.w3.org/2001/XMLSchema#string

Robert L Sutherland

http://www.w3.org/2001/XMLSchema#string

P2860

Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice

Chromosome 11q13 abnormalities in human breast cancer

A novel cyclin encoded by a bcl1-linked candidate oncogene

Cancer cell cycles

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.

Role of erbB2 in breast cancer chemosensitivity.

Specific protection against breast cancers by cyclin D1 ablation.

Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.

Blocking oncogenic Ras signaling for cancer therapy.

P2888

P304

14-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR411

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11482458

http://www.w3.org/2001/XMLSchema#string

P6179

1046816548

http://www.w3.org/2001/XMLSchema#string

P698

11879554

http://www.w3.org/2001/XMLSchema#string

P921

invasive mammary ductal carcinoma

Chin-hu̍t seng-bu̍t

proto-oncogene proteins

biomedical investigative technique

neoplasm proteins

cell cycle proteins

P932

154565

http://www.w3.org/2001/XMLSchema#string